Thursday, October 30, 2025

Top 5 This Week

Related News

Dr. Reddy’s Laboratories appoints Srinivas Mallavarapu as Chief of Global Portfolio and Head of Business Development for North America

Wishing Mr. Srinivas Mallavarapu greater responsibilities and exciting challenges in this impressive new chapter!

Mr. Mallavarapu brings more than twenty years of experience in the pharmaceutical industry with deep expertise in portfolio strategy, complex generics, and business expansion across global markets.

Srinivas returns to Dr. Reddy’s after his recent role at Cipla where he served as Executive Vice President Global Portfolio and Business Development. At Cipla he guided the development of the global product pipeline and led cross functional teams to support growth across complex generics, specialty injectables, and products with high entry barriers in the United States and Canada. His work played a key role in shaping strategic partnerships and strengthening the company’s presence in major international markets.

Before joining Cipla, Srinivas held leadership positions at Dr. Reddy’s Laboratories including Senior Director Strategic Portfolio and Business Development and Director US Portfolio Management. During his earlier tenure he contributed to product launch strategies, long term pipeline planning, and collaborations that expanded the company’s reach in leading global markets.

Srinivas began his career at Keane Software Solutions where he built strong analytical and strategic planning skills that later supported his approach to portfolio management and business growth in the pharmaceutical sector. Over the years he has earned a reputation for combining market understanding with strategic foresight to create value across product categories and geographies.

In his new role at Dr. Reddy’s, Srinivas will focus on advancing the company’s North America business while strengthening its global portfolio strategy. He will work on driving innovation, enhancing strategic partnerships, and supporting the company’s goal of sustainable growth in generics and specialty segments.

Also read: Viksit Workforce for a Viksit Bharat

Do Follow: The Mainstream formerly known as CIO News LinkedIn Account | The Mainstream formerly known as CIO News Facebook | The Mainstream formerly known as CIO News Youtube | The Mainstream formerly known as CIO News Twitter |The Mainstream formerly known as CIO News Whatsapp Channel | The Mainstream formerly known as CIO News Instagram

About us:

The Mainstream formerly known as CIO News is a premier platform dedicated to delivering latest news, updates, and insights from the tech industry. With its strong foundation of intellectual property and thought leadership, the platform is well-positioned to stay ahead of the curve and lead conversations about how technology shapes our world. From its early days as CIO News to its rebranding as The Mainstream on November 28, 2024, it has been expanding its global reach, targeting key markets in the Middle East & Africa, ASEAN, the USA, and the UK. The Mainstream is a vision to put technology at the center of every conversation, inspiring professionals and organizations to embrace the future of tech.

Popular Articles